ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

Inclusion Criteria: * You have a diagnosis of non-small cell lung cancer. * You have received no prior chemotherapy. * You have at least one measurable lesion. * You have an adequate performance status. * You are at least 18 years of age. Exclusion Criteria: * You have previously received chemotherapy for your lung cancer. * You have received radiation within the last 30 days. * You have active infection or other serious condition. * You have brain metastasis. * You have recently lost a significant amount of weight.